FDA panel takes up tough questions on J&J COVID-19 boosters | iNFOnews | Thompson-Okanagan's News Source
WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing growing worry that Americans who got the single-dose shot aren’t as protected as those given two-dose brands.